SG11202013207XA - Graphene product and therapeutic uses thereof - Google Patents

Graphene product and therapeutic uses thereof

Info

Publication number
SG11202013207XA
SG11202013207XA SG11202013207XA SG11202013207XA SG11202013207XA SG 11202013207X A SG11202013207X A SG 11202013207XA SG 11202013207X A SG11202013207X A SG 11202013207XA SG 11202013207X A SG11202013207X A SG 11202013207XA SG 11202013207X A SG11202013207X A SG 11202013207XA
Authority
SG
Singapore
Prior art keywords
therapeutic uses
graphene product
graphene
product
therapeutic
Prior art date
Application number
SG11202013207XA
Inventor
Rovira Martín Martínez
Rovira José Antonio Martínez
López María Del Prado Lavín
Izquierdo Amaya Romero
Puyol Manuel Rodríguez
Puyol Diego Rodríguez
Frutos García Sergio De
Merino Mercedes Griera
Vaquero Marco Antonio Hatem
Agudo Ana Isabel Orozco
Original Assignee
Graphenano Medical Care S L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Graphenano Medical Care S L filed Critical Graphenano Medical Care S L
Publication of SG11202013207XA publication Critical patent/SG11202013207XA/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C01INORGANIC CHEMISTRY
    • C01BNON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
    • C01B32/00Carbon; Compounds thereof
    • C01B32/15Nano-sized carbon materials
    • C01B32/18Nanoonions; Nanoscrolls; Nanohorns; Nanocones; Nanowalls
    • CCHEMISTRY; METALLURGY
    • C01INORGANIC CHEMISTRY
    • C01BNON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
    • C01B32/00Carbon; Compounds thereof
    • C01B32/15Nano-sized carbon materials
    • C01B32/182Graphene
    • C01B32/184Preparation
    • C01B32/19Preparation by exfoliation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/44Elemental carbon, e.g. charcoal, carbon black
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/06Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/10Anti-acne agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B82NANOTECHNOLOGY
    • B82YSPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y30/00Nanotechnology for materials or surface science, e.g. nanocomposites
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B82NANOTECHNOLOGY
    • B82YSPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y40/00Manufacture or treatment of nanostructures
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B82NANOTECHNOLOGY
    • B82YSPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • CCHEMISTRY; METALLURGY
    • C01INORGANIC CHEMISTRY
    • C01BNON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
    • C01B32/00Carbon; Compounds thereof
    • C01B32/15Nano-sized carbon materials
    • C01B32/182Graphene
    • CCHEMISTRY; METALLURGY
    • C01INORGANIC CHEMISTRY
    • C01BNON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
    • C01B32/00Carbon; Compounds thereof
    • C01B32/15Nano-sized carbon materials
    • C01B32/182Graphene
    • C01B32/198Graphene oxide
    • CCHEMISTRY; METALLURGY
    • C01INORGANIC CHEMISTRY
    • C01BNON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
    • C01B2204/00Structure or properties of graphene
    • C01B2204/20Graphene characterized by its properties
    • C01B2204/30Purity
    • CCHEMISTRY; METALLURGY
    • C01INORGANIC CHEMISTRY
    • C01BNON-METALLIC ELEMENTS; COMPOUNDS THEREOF; METALLOIDS OR COMPOUNDS THEREOF NOT COVERED BY SUBCLASS C01C
    • C01B2204/00Structure or properties of graphene
    • C01B2204/20Graphene characterized by its properties
    • C01B2204/32Size or surface area
    • CCHEMISTRY; METALLURGY
    • C01INORGANIC CHEMISTRY
    • C01PINDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
    • C01P2002/00Crystal-structural characteristics
    • C01P2002/01Crystal-structural characteristics depicted by a TEM-image
    • CCHEMISTRY; METALLURGY
    • C01INORGANIC CHEMISTRY
    • C01PINDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
    • C01P2002/00Crystal-structural characteristics
    • C01P2002/70Crystal-structural characteristics defined by measured X-ray, neutron or electron diffraction data
    • C01P2002/72Crystal-structural characteristics defined by measured X-ray, neutron or electron diffraction data by d-values or two theta-values, e.g. as X-ray diagram
    • CCHEMISTRY; METALLURGY
    • C01INORGANIC CHEMISTRY
    • C01PINDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
    • C01P2002/00Crystal-structural characteristics
    • C01P2002/70Crystal-structural characteristics defined by measured X-ray, neutron or electron diffraction data
    • C01P2002/74Crystal-structural characteristics defined by measured X-ray, neutron or electron diffraction data by peak-intensities or a ratio thereof only
    • CCHEMISTRY; METALLURGY
    • C01INORGANIC CHEMISTRY
    • C01PINDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
    • C01P2002/00Crystal-structural characteristics
    • C01P2002/80Crystal-structural characteristics defined by measured data other than those specified in group C01P2002/70
    • C01P2002/82Crystal-structural characteristics defined by measured data other than those specified in group C01P2002/70 by IR- or Raman-data
    • CCHEMISTRY; METALLURGY
    • C01INORGANIC CHEMISTRY
    • C01PINDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
    • C01P2004/00Particle morphology
    • C01P2004/01Particle morphology depicted by an image
    • C01P2004/03Particle morphology depicted by an image obtained by SEM
    • CCHEMISTRY; METALLURGY
    • C01INORGANIC CHEMISTRY
    • C01PINDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
    • C01P2004/00Particle morphology
    • C01P2004/01Particle morphology depicted by an image
    • C01P2004/04Particle morphology depicted by an image obtained by TEM, STEM, STM or AFM
    • CCHEMISTRY; METALLURGY
    • C01INORGANIC CHEMISTRY
    • C01PINDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
    • C01P2004/00Particle morphology
    • C01P2004/51Particles with a specific particle size distribution
    • CCHEMISTRY; METALLURGY
    • C01INORGANIC CHEMISTRY
    • C01PINDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
    • C01P2004/00Particle morphology
    • C01P2004/60Particles characterised by their size
    • C01P2004/61Micrometer sized, i.e. from 1-100 micrometer
    • CCHEMISTRY; METALLURGY
    • C01INORGANIC CHEMISTRY
    • C01PINDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
    • C01P2006/00Physical properties of inorganic compounds
    • C01P2006/12Surface area
    • CCHEMISTRY; METALLURGY
    • C01INORGANIC CHEMISTRY
    • C01PINDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
    • C01P2006/00Physical properties of inorganic compounds
    • C01P2006/14Pore volume
    • CCHEMISTRY; METALLURGY
    • C01INORGANIC CHEMISTRY
    • C01PINDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
    • C01P2006/00Physical properties of inorganic compounds
    • C01P2006/16Pore diameter
    • CCHEMISTRY; METALLURGY
    • C01INORGANIC CHEMISTRY
    • C01PINDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
    • C01P2006/00Physical properties of inorganic compounds
    • C01P2006/40Electric properties
    • CCHEMISTRY; METALLURGY
    • C01INORGANIC CHEMISTRY
    • C01PINDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
    • C01P2006/00Physical properties of inorganic compounds
    • C01P2006/80Compositional purity

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nanotechnology (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Materials Engineering (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • General Physics & Mathematics (AREA)
  • Physics & Mathematics (AREA)
  • Condensed Matter Physics & Semiconductors (AREA)
  • Biophysics (AREA)
  • Manufacturing & Machinery (AREA)
  • Composite Materials (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SG11202013207XA 2018-07-17 2019-07-17 Graphene product and therapeutic uses thereof SG11202013207XA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP18382531.4A EP3597594A1 (en) 2018-07-17 2018-07-17 Graphene product and therapeutic uses thereof
PCT/EP2019/069288 WO2020016324A1 (en) 2018-07-17 2019-07-17 Graphene product and therapeutic uses thereof

Publications (1)

Publication Number Publication Date
SG11202013207XA true SG11202013207XA (en) 2021-01-28

Family

ID=62986031

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202013207XA SG11202013207XA (en) 2018-07-17 2019-07-17 Graphene product and therapeutic uses thereof

Country Status (14)

Country Link
US (1) US20210292171A1 (en)
EP (2) EP3597594A1 (en)
JP (1) JP7381113B2 (en)
KR (1) KR20210031495A (en)
CN (1) CN112469664B (en)
AU (1) AU2019304509A1 (en)
BR (1) BR112021000641A2 (en)
CA (1) CA3104638A1 (en)
ES (1) ES2964222T3 (en)
IL (1) IL280150A (en)
MX (1) MX2021000583A (en)
RU (1) RU2765294C1 (en)
SG (1) SG11202013207XA (en)
WO (1) WO2020016324A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3597595A1 (en) * 2018-07-17 2020-01-22 Graphenano Medical Care, S.L. Graphene product and cosmetic uses thereof
CN112057747B (en) * 2020-08-17 2021-05-07 菏泽鑫盛达新材料有限公司 Graphene material for hot compress material and preparation method thereof
EP4079284A1 (en) 2021-04-23 2022-10-26 Graphenano Medical Care, S.L. A graphene nanomaterial for use as a fat adborbent

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU605920B2 (en) 1987-10-21 1991-01-24 Atochem North America, Inc. Morpholinyl silanes and use for control of plant diseases caused by fungi
US20060134096A1 (en) 2004-12-22 2006-06-22 Supracarbonic, Llc Compositions and methods for medical use of graphene-containing compositions
EP2392700B1 (en) * 2010-04-28 2012-06-20 Teijin Aramid B.V. Process for spinning graphene ribbon fibers
CN102690648B (en) * 2011-03-22 2016-05-18 北京师范大学 Graphene fluorescent nano material, its preparation and application
US9572834B2 (en) 2011-04-26 2017-02-21 William Marsh Rice University Use of carbon nanomaterials with antioxidant properties to treat oxidative stress
JP2014527020A (en) * 2011-09-14 2014-10-09 ウィリアム・マーシュ・ライス・ユニバーシティ Solution-based method for producing graphene nanoribbons
JP2013133257A (en) 2011-12-26 2013-07-08 Toshiba Corp Method and apparatus for producing nano-graphene
US20160193249A1 (en) * 2013-09-03 2016-07-07 William Marsh Rice University Treatment of inflammatory diseases by carbon materials
CN103482620B (en) * 2013-09-11 2016-01-20 黄镇东 Oxidation or reduced graphene base net grid material and preparation method thereof
GB2532449A (en) 2014-11-19 2016-05-25 Univ Manchester Use of Nanomaterials in treating cancer
JP2016158680A (en) * 2015-02-27 2016-09-05 国立大学法人北海道大学 Scaffold for osteoanagenesis or for skin regeneration using graphene oxide
CN106521719A (en) * 2016-11-10 2017-03-22 过冬 Graphene-based carbon nanofiber preparation method
CN107137753B (en) * 2017-05-09 2020-03-31 重庆大学 Preparation method of graphene/carbon nanofiber biomedical external application non-woven fabric
EP3597595A1 (en) 2018-07-17 2020-01-22 Graphenano Medical Care, S.L. Graphene product and cosmetic uses thereof

Also Published As

Publication number Publication date
EP3823928B1 (en) 2023-10-11
KR20210031495A (en) 2021-03-19
JP2021532045A (en) 2021-11-25
JP7381113B2 (en) 2023-11-15
WO2020016324A1 (en) 2020-01-23
BR112021000641A2 (en) 2021-04-06
US20210292171A1 (en) 2021-09-23
IL280150A (en) 2021-03-01
EP3823928A1 (en) 2021-05-26
AU2019304509A1 (en) 2021-01-28
EP3823928C0 (en) 2023-10-11
CA3104638A1 (en) 2020-01-23
RU2765294C1 (en) 2022-01-28
EP3597594A1 (en) 2020-01-22
ES2964222T3 (en) 2024-04-04
MX2021000583A (en) 2021-06-23
CN112469664A (en) 2021-03-09
CN112469664B (en) 2023-07-14

Similar Documents

Publication Publication Date Title
EP3720502A4 (en) Cytobiologics and therapeutic uses thereof
IL280152A (en) Graphene product and cosmetic uses thereof
IL280150A (en) Graphene product and therapeutic uses thereof
GB201617064D0 (en) Compounds and their therapeutic use
GB201715194D0 (en) Compounds and their therapeutic use
ZA201905372B (en) Therapeutic and neuroprotective peptides
HK1254461A1 (en) Modified cytotoxins and their therapeutic use
IL290742A (en) Graphene and the production of graphene
SG11202104590SA (en) Graphene production and composition
IL270011B (en) Therapeutic compounds and methods
IL265269B (en) Novel compounds and therapeutic uses thereof
EP3302530A4 (en) Cdh26 based therapeutic agents and their use
ZA201904386B (en) S-arrestin peptides and therapeutic uses thereof
GB201802122D0 (en) Product and use
EP3600439A4 (en) Modified oligonucleotides and therapeutic uses thereof
GB201804098D0 (en) Novel compounds and therapeutic uses thereof
GB201700526D0 (en) Therapeutic use
EP3204003A4 (en) Selenosugars and therapeutic uses thereof
EP3664800A4 (en) Therapeutic formulations and uses thereof
EP3636712C0 (en) Fluororubber composition and fluororubber crosslinked product
IL270460B1 (en) Novel compounds and therapeutic uses thereof
IL282157A (en) Compounds and therapeutic uses thereof
GB201707076D0 (en) Novel compounds and therapeutic uses thereof
GB201705682D0 (en) Novel compounds and therapeutic uses thereof
GB201705683D0 (en) Novel compounds and therapeutic uses thereof